1375 West Fulton Market
Suite 700
Chicago, IL 60607
United States
650 433 3000
https://talisbio.com
Settore/i: Healthcare
Settore: Medical Devices
Impiegati a tempo pieno: 99
Nome | Titolo | Retribuzione | Esercitate | Anno di nascita |
---|---|---|---|---|
Mr. Robert Kelley MBA | CEO & Director | 852,36k | N/D | 1972 |
Dr. Andrew A. Lukowiak Ph.D. | President & Chief Scientific Officer | 904,9k | N/D | 1973 |
Dr. Rustem F. Ismagilov Ph.D. | Co-Founder & Director | 53,95k | N/D | 1974 |
Ms. Rebecca Markovich | Interim Chief Financial Officer | 379,23k | N/D | 1974 |
Mr. Liang Li Ph.D. | Co-Founder and Director of Technology & Strategy | N/D | N/D | N/D |
Ms. Emily Faucette | Senior Vice President of Corporate Communications & Investor Relations | N/D | N/D | N/D |
Ms. Jill Green | Senior Vice President of Legal | N/D | N/D | N/D |
Mr. Matthew Pepe | Vice President of Human Resource | N/D | N/D | N/D |
Ms. Margaret Barrett M.S. | Controller | N/D | N/D | N/D |
Gillian Green | Company Secretary | N/D | N/D | N/D |
Talis Biomedical Corporation operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.
L'ISS Governance QualityScore di Talis Biomedical Corporation al 1 maggio 2024 è 9. I criteri di valutazione fondamentali sono revisione: 9; Consiglio di Amministrazione: 10; diritti degli azionisti: 7; retribuzione: 9.